Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data
Lorenzo Nesti, Andrea Natali
Nutrition Metabolism and Cardiovascular Diseases (2017) Vol. 27, Iss. 8, pp. 657-669
Closed Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado, Gina Manda, Ahmed Hassan, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 348-383
Open Access | Times Cited: 537
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 194
Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases
Wenjun Wang, Peter M. Kang
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1292-1292
Open Access | Times Cited: 147
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
Nadezda Apostolova, Francesca Iannantuoni, Aleksandra Gruevska, et al.
Redox Biology (2020) Vol. 34, pp. 101517-101517
Open Access | Times Cited: 140
The effects of metformin on autophagy
Guangli Lu, Zhen Wu, Jia Shang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111286-111286
Open Access | Times Cited: 123
Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications
Jin Feng, Xiaohui Wang, Xiaochun Ye, et al.
Pharmacological Research (2022) Vol. 177, pp. 106114-106114
Closed Access | Times Cited: 105
Metformin: Therapeutic profile in the treatment of type 2 diabetes
Clifford J. Bailey
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 3-19
Open Access | Times Cited: 18
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
Mohapradeep Mohan, Shaween Al-Talabany, Angela McKinnie, et al.
European Heart Journal (2019) Vol. 40, Iss. 41, pp. 3409-3417
Open Access | Times Cited: 133
Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus
Petter Bjornstad, Michal Schäfer, Uyen Truong, et al.
Circulation (2018) Vol. 138, Iss. 25, pp. 2895-2907
Open Access | Times Cited: 119
Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
Go J. Yoshida, Arata Azuma, Yukiko Miura, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2256-2256
Open Access | Times Cited: 114
Metformin as a geroprotector: experimental and clinical evidence
Veronika Piskovatska, Nadya Stefanyshyn, Kenneth B. Storey, et al.
Biogerontology (2018) Vol. 20, Iss. 1, pp. 33-48
Closed Access | Times Cited: 105
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Józef Drzewoski, M Hanefeld
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 122-122
Open Access | Times Cited: 102
Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes
Matthew J. O’Brien, Susan Karam, Amisha Wallia, et al.
JAMA Network Open (2018) Vol. 1, Iss. 8, pp. e186125-e186125
Open Access | Times Cited: 95
AMPK: a therapeutic target of heart failure—not only metabolism regulation
Xuan Li, Jia Liu, Qingguo Lü, et al.
Bioscience Reports (2018) Vol. 39, Iss. 1
Open Access | Times Cited: 87
Mechanism and application of metformin in kidney diseases: An update
Anni Song, Chun Zhang, Xianfang Meng
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111454-111454
Open Access | Times Cited: 85
A review of phenformin, metformin, and imeglimin
Raghunandan Yendapally, Donald Sikazwe, Subin S. Kim, et al.
Drug Development Research (2020) Vol. 81, Iss. 4, pp. 390-401
Closed Access | Times Cited: 81
Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Lorenzo Nesti, Domenico Tricò, Alessandro Mengozzi, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 80
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Konstantinos Evangelou, Panagiotis Vasileiou, Angelos Papaspyropoulos, et al.
Physiological Reviews (2022) Vol. 103, Iss. 1, pp. 609-647
Open Access | Times Cited: 57
Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis
Sabrina Robichaud, Adil Rasheed, Antonietta Pietrangelo, et al.
Circulation Research (2022) Vol. 130, Iss. 6, pp. 831-847
Open Access | Times Cited: 52
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure
Guntram Schernthaner, K. Brand, Clifford J. Bailey
Metabolism (2022) Vol. 130, pp. 155160-155160
Open Access | Times Cited: 42
Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells <i>via</i> the PI3K/AKT/mTOR pathway
Bo Xu, Wenjie Dai, Ling Liu, et al.
Endocrine Journal (2022) Vol. 69, Iss. 7, pp. 863-875
Open Access | Times Cited: 39
Windows of Susceptibility to Air Pollution During and Surrounding Pregnancy in Relation to Longitudinal Maternal Measures of Adiposity and Lipid Profiles
Sandra India Aldana, Danielle Demateis, Damaskini Valvi, et al.
Environmental Research (2025), pp. 121198-121198
Closed Access | Times Cited: 1
Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients
Habib Yaribeygi, Alexandra E. Butler, George E. Barreto, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2436-2446
Closed Access | Times Cited: 81
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
Tseng Chin-Hsiao
Aging and Disease (2018) Vol. 10, Iss. 1, pp. 37-37
Open Access | Times Cited: 80
AMPK and cardiac remodelling
Yenan Feng, Youyi Zhang, Han Xiao
Science China Life Sciences (2017) Vol. 61, Iss. 1, pp. 14-23
Closed Access | Times Cited: 73
Page 1 - Next Page

Scroll to top